Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Eivor Örnskov, Ph.D.
Principal Scientist, Pharmaceutical Sciences at AstraZeneca Gothenburg
Speaker

Profile

Eivor Örnskov is a Principal Scientist at AstraZeneca in Gothenburg, Sweden, where she leads development of the analytical characterization platform for the company’s novel lipid nanoparticle (LNP) drug products. She earned her PhD in analytical chemistry from Uppsala University in 2004. At AstraZeneca, Eivor has developed numerous release and stability methods that support both preclinical and clinical programs. She has also authored regulatory submissions and published peer-reviewed work about mRNA characterization.

Agenda Sessions

  • Insights into mRNA Higher-Order Structure and Impact on Integrity Analyses

    , 8:30am
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Eivor at TIDES USA: Oligonucleotide & Peptide Therapeutics